Biology-driven cancer drug development: back to the future - Wikidata - awgldk - TriplyDB

Biology-driven cancer drug development: back to the future

Biology-driven cancer drug development: back to the future

http://www.wikidata.org/entity/Q33552888

about

Identifying potential indicators to measure the outcome of translational cancer research: a mixed methods approach Systems pathology.DNA repair in cancer: emerging targets for personalized therapy.What can molecular pathology contribute to the management of renal cell carcinoma?Functional drug-gene interactions in lung cancer.Modular pharmacology: the next paradigm in drug discovery.Mathematical and statistical modeling in cancer systems biology The SOX family of genes in cancer development: biological relevance and opportunities for therapy.Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer Drugs for solid cancer: the productivity crisis prompts a rethink.A chemical-genetic interaction map of small molecules using high-throughput imaging in cancer cells.Plus ça change The hope of progress Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer

P2860

Q27303882-C40449E1-A3C4-43A4-8C8A-83EFF97E2857 Q34423466-BF54729B-1BCE-4EF9-A4D1-26BD5E8E28F7 Q37600799-F0A73B9C-480A-4EC4-A044-5E02F1C18318 Q37864528-5D21F792-E36C-43D9-903F-069E3F82602F Q37999073-B69A909F-2067-40FA-9608-F736E7BED697 Q38017212-2D936368-FD3E-4D02-80A7-1BFB1F2BD552 Q38023403-577F4908-E87D-4D70-B718-56E4EA4393D5 Q38029732-9152D1D3-924C-4F2A-83D0-C39DCD8B9E2C Q38790859-4A880D3F-1975-4BB4-AF19-E051F1720F91 Q41094610-6849F09E-FA71-4F33-B59F-2B33DC02A677 Q41313977-DBC1C0AE-90CF-4030-9E60-FE504B09371D Q42675375-25029ECA-2A39-4556-B5A6-C20797F300D8 Q42793631-41DDE719-51FB-4129-A441-842CC4B3666B Q42793638-EE34BB59-39E3-4621-87FE-437FB4BABD89 Q58623046-30566244-C105-481E-A754-1AAFB59C229D

P2860

Biology-driven cancer drug development: back to the future

http://www.wikidata.org/entity/Q33552888

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Biology-driven cancer drug development: back to the future

@ast

Biology-driven cancer drug development: back to the future

@en

Biology-driven cancer drug development: back to the future.

@nl

type

label

Biology-driven cancer drug development: back to the future

@ast

Biology-driven cancer drug development: back to the future

@en

Biology-driven cancer drug development: back to the future.

@nl

prefLabel

Biology-driven cancer drug development: back to the future

@ast

Biology-driven cancer drug development: back to the future

@en

Biology-driven cancer drug development: back to the future.

@nl

P1433

Q33552888-1D70F811-7B62-4A51-A73F-0BE4451DB34B

P1476

Q33552888-4D0A7626-76EA-4066-92B6-CD6387D03813

P2860

Q33552888-0205F720-A382-4F95-82A8-B78CBD74F6D1

Q33552888-02E1072B-63FC-4B29-8A87-6A5FC2E53B59

Q33552888-037F536C-4A81-4417-88B9-25B0D9CE6FFE

Q33552888-0477D9AA-91AC-4F6C-B67B-AB3E6A820ADA

Q33552888-063BC888-27FE-4C5B-B803-736A6D202E10

Q33552888-0AD9F69A-10A2-4547-AE0F-CB8FCF361E59

Q33552888-0B05F852-02DD-4FC7-903E-2C40EB86A56F

Q33552888-0E67DAF4-D81B-4995-8715-ABA0AAC51AE8

Q33552888-0EFF3CE0-34F0-425D-B999-E5C6D238CD1B

Q33552888-14FC5C9F-AF54-414F-8D11-02447B9C7C5C

P2888

Q33552888-36C594DB-4865-4060-BE68-CE7F1FE6D373

P304

Q33552888-B713F586-7E77-42F9-B4DD-7E824DFE1241

P31

Q33552888-533DA70C-466B-414F-B45B-8F066CF0E344

Q33552888-EEEC468F-9A16-4E12-89A5-83FBCDF089C9

P356

Q33552888-80ED817E-78AD-4E07-A3C2-71032CD30912

P478

Q33552888-346BE163-F3E8-4B54-A3A7-5384BD681C05

P50

Q33552888-8EA50BD4-C3E2-48D4-88C1-06A9D27B7C66

Q33552888-DFF0852B-A54A-43D8-ADE7-FC4DE5C93762

P577

Q33552888-59BB48B8-C60B-4FE0-B14A-2B31C34F257D

P5875

Q33552888-8FC22672-C7F0-4824-975A-9328074AEFDB

P6179

Q33552888-8C5863DF-C70D-4F41-AFFE-F78C32A448C8

P698

Q33552888-C34CBEA4-ADF7-44AA-8EF0-A7F847ADD6BA

P921

Q33552888-E14EFADC-E41B-46AA-B3F3-38AFFE5B5082

Q33552888-FFD4DD44-7239-418B-944D-E10D4755FFBF

P932

Q33552888-F4F67E0E-FA4D-4433-86CC-1A97282CFD55

P356

P1433

P1476

Biology-driven cancer drug development: back to the future

@en

P2860

DNA Damage, Aging, and Cancer

The Hallmarks of Cancer

Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF

A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474

A small-cell lung cancer genome with complex signatures of tobacco exposure

A comprehensive catalogue of somatic mutations from a human cancer genome

Complex landscapes of somatic rearrangement in human breast cancer genomes.

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

P2888

P304

38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7007-8-38

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Christopher J Lord

P577

2010-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43130247

http://www.w3.org/2001/XMLSchema#string

P6179

1027575185

http://www.w3.org/2001/XMLSchema#string

P698

20385032

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

2864096

http://www.w3.org/2001/XMLSchema#string